Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-18-000110
Filing Date
2018-01-17
Accepted
2018-01-17 08:45:49
Documents
47
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pscr_10q.htm 10-Q 224630
2 CERTIFICATION pscr_ex311.htm EX-31.1 8332
3 CERTIFICATION pscr_ex312.htm EX-31.2 8259
4 CERTIFICATION pscr_ex321.htm EX-32.1 3968
  Complete submission text file 0001640334-18-000110.txt   1999044

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT pscr-20170630.xml EX-101.INS 328543
6 XBRL TAXONOMY EXTENSION SCHEMA pscr-20170630.xsd EX-101.SCH 25117
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pscr-20170630_cal.xml EX-101.CAL 37035
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pscr-20170630_def.xml EX-101.DEF 88229
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pscr-20170630_lab.xml EX-101.LAB 169796
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pscr-20170630_pre.xml EX-101.PRE 153922
Mailing Address 9830 6TH STREET, SUITE 103 RANCHO CUCAMONGA CA 91730
Business Address 9830 6TH STREET, SUITE 103 RANCHO CUCAMONGA CA 91730 (855) 476-7679
PROTO SCRIPT PHARMACEUTICAL CORP (Filer) CIK: 0001521420 (see all company filings)

EIN.: 990363803 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-175146 | Film No.: 18529818
SIC: 7330 Services-Mailing, Reproduction, Commercial Art & Photography